Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Is TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?

Trimethylamine N-oxide is formed through a gut microbe-dependent step that converts dietary choline and carnitine to trimethylamine, which the liver then oxidizes to TMAO.

PlausibleSeptember 16, 20263 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Trimethylamine N-oxide is produced when gut microbes convert dietary precursors such as choline and carnitine into trimethylamine, which the liver then oxidizes to trimethylamine N-oxide.

laying out figure…
1 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes a sequential host–microbiome pathway rather than a direct effect of eating choline or carnitine. The mechanism graph frames this as microbial production of trimethylamine, with hepatic oxidation afterward as the conversion step that yields trimethylamine N-oxide. It also reflects that carnitine can pass through γ-butyrobetaine as an intermediate in the pathway.

Verified conclusion

Trimethylamine N-oxide (TMAO) formation is a sequential host–microbiome pathway rather than a direct effect of consuming choline or carnitine. The claim is well supported by human intervention and mechanistic enzyme evidence.

Clinical and metabolic evidence

  • Human isotope-challenge studies show that ingested phosphatidylcholine and L-carnitine give rise to labeled circulating and urinary TMAO. During treatment with poorly absorbed broad-spectrum antibiotics, labeled TMAO production was nearly eliminated or abolished and returned after antibiotics were stopped, demonstrating that gut microbes are required for the TMA-generating step.
  • Choline and betaine could still increase despite antibiotic suppression of labeled TMAO, consistent with microbial dependence being specific to conversion toward TMA rather than absorption of all dietary choline-derived compounds.
  • The carnitine pathway includes a documented intermediate: L-carnitine → γ-butyrobetaine → TMA → TMAO. Post-carnitine TMAO production was markedly lower in vegans/vegetarians than in omnivores, indicating that habitual diet can shape microbial capacity for this metabolism.

Mechanism

  • After intestinal production and absorption of TMA, the liver predominantly converts it to TMAO through flavin-containing monooxygenase 3 (FMO3). This is an NADPH- and molecular-oxygen-dependent N-oxidation reaction.
  • Recombinant human FMO3 directly catalyzes TMA-to-TMAO conversion. Reduced FMO3 activity or pathogenic variants impair TMA N-oxygenation and cause trimethylaminuria, while experimental FMO3 modulation changes circulating TMAO in the expected direction.
  • Other flavin-containing monooxygenases may contribute, but FMO3 is the principal hepatic enzyme.

Bottom line

  • The stated pathway is scientifically well established: gut microbial metabolism converts dietary choline and carnitine—often via γ-butyrobetaine for carnitine—to TMA, and hepatic FMO3 predominantly oxidizes TMA to TMAO.

References

  1. Intestinal Microbial Metabolism of Phosphatidylcholine and ... — masspec.scripps.edu ↗
  2. Microbiome, Trimethylamine N-Oxide (TMAO), and ... — pmc.ncbi.nlm.nih.gov ↗
  3. Impact of trimethylamine N-oxide (TMAO) metaorganismal pathway ... — jlpm.amegroups.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible7 sourcesDoes a TMAO result reflect diet, gut conversion, liver oxidation, and kidney clearance together?→